CGTX Aligns Pivotal Study
Cognition Therapeutics aligns on key aspects of pivotal study for Zervimesine in DLB psychosis after receiving FDA meeting minutes
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.